| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.416 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.306 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.306 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.218 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.208 | |
| circulatory system process | GO:0003013 | 197 | 0.183 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.151 | |
| male gamete generation | GO:0048232 | 285 | 0.148 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.136 | |
| stem cell differentiation | GO:0048863 | 268 | 0.128 | |
| spleen development | GO:0048536 | 39 | 0.122 | |
| spermatid differentiation | GO:0048515 | 115 | 0.120 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.119 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.111 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.105 | |
| ovulation cycle | GO:0042698 | 59 | 0.104 | |
| sperm motility | GO:0030317 | 47 | 0.103 | |
| transmembrane transport | GO:0055085 | 412 | 0.103 | |
| multicellular organism growth | GO:0035264 | 161 | 0.103 | |
| translation | GO:0006412 | 93 | 0.102 | |
| regulation of defense response | GO:0031347 | 233 | 0.101 | |
| fertilization | GO:0009566 | 127 | 0.097 | |
| spermatogenesis | GO:0007283 | 284 | 0.096 | |
| spermatid development | GO:0007286 | 108 | 0.095 | |
| skeletal system development | GO:0001501 | 356 | 0.091 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.091 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.088 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.088 | |
| cation transport | GO:0006812 | 399 | 0.087 | |
| renal system development | GO:0072001 | 225 | 0.086 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.086 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.086 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.084 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.083 | |
| cation homeostasis | GO:0055080 | 212 | 0.083 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.082 | |
| ossification | GO:0001503 | 216 | 0.079 | |
| positive regulation of growth | GO:0045927 | 104 | 0.078 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.077 | |
| bone development | GO:0060348 | 120 | 0.077 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.076 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.076 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.074 | |
| mapk cascade | GO:0000165 | 281 | 0.072 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.072 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.071 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.071 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.069 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.069 | |
| sodium ion transport | GO:0006814 | 73 | 0.067 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.067 | |
| blood circulation | GO:0008015 | 195 | 0.067 | |
| locomotory behavior | GO:0007626 | 195 | 0.064 | |
| gland development | GO:0048732 | 330 | 0.063 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.063 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.062 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.061 | |
| male gonad development | GO:0008584 | 88 | 0.060 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.060 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.060 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.060 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.059 | |
| regulation of system process | GO:0044057 | 200 | 0.058 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.057 | |
| cytokine production | GO:0001816 | 319 | 0.056 | |
| female sex differentiation | GO:0046660 | 84 | 0.056 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.056 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.055 | |
| regulation of secretion | GO:0051046 | 274 | 0.054 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.054 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.054 | |
| lung development | GO:0030324 | 164 | 0.053 | |
| oxidation reduction process | GO:0055114 | 342 | 0.052 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.052 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.052 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.052 | |
| phenol containing compound metabolic process | GO:0018958 | 60 | 0.051 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.051 | |
| protein catabolic process | GO:0030163 | 221 | 0.051 | |
| camera type eye development | GO:0043010 | 266 | 0.051 | |
| cellular homeostasis | GO:0019725 | 240 | 0.051 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.050 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.050 | |
| immune effector process | GO:0002252 | 321 | 0.050 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.050 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.049 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.049 | |
| forebrain development | GO:0030900 | 302 | 0.049 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.049 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.049 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.049 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.048 | |
| rhythmic process | GO:0048511 | 174 | 0.048 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.047 | |
| female gonad development | GO:0008585 | 71 | 0.047 | |
| stem cell development | GO:0048864 | 219 | 0.047 | |
| cell adhesion | GO:0007155 | 329 | 0.047 | |
| organelle assembly | GO:0070925 | 177 | 0.046 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.046 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.045 | |
| neuromuscular process | GO:0050905 | 99 | 0.045 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.045 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.045 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.045 | |
| amine metabolic process | GO:0009308 | 45 | 0.044 | |
| nuclear transport | GO:0051169 | 139 | 0.044 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.044 | |
| cell maturation | GO:0048469 | 127 | 0.044 | |
| muscle tissue development | GO:0060537 | 308 | 0.044 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.044 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.043 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.043 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.043 | |
| insulin secretion | GO:0030073 | 89 | 0.043 | |
| peripheral nervous system development | GO:0007422 | 53 | 0.042 | |
| plasma cell differentiation | GO:0002317 | 3 | 0.042 | |
| striated muscle cell proliferation | GO:0014855 | 39 | 0.042 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.042 | |
| sclerotome development | GO:0061056 | 4 | 0.042 | |
| amide transport | GO:0042886 | 138 | 0.042 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.041 | |
| bronchiole morphogenesis | GO:0060436 | 1 | 0.041 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.040 | |
| tissue homeostasis | GO:0001894 | 115 | 0.040 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.039 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.039 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.039 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.039 | |
| epidermis development | GO:0008544 | 187 | 0.039 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.039 | |
| metanephric dct cell differentiation | GO:0072240 | 3 | 0.039 | |
| chemotaxis | GO:0006935 | 247 | 0.038 | |
| purkinje myocyte differentiation | GO:0003168 | 1 | 0.038 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.038 | |
| camp metabolic process | GO:0046058 | 40 | 0.038 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.038 | |
| positive regulation of white fat cell proliferation | GO:0070352 | 1 | 0.038 | |
| heterophilic cell cell adhesion via plasma membrane cell adhesion molecules | GO:0007157 | 20 | 0.037 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.037 | |
| germ cell development | GO:0007281 | 185 | 0.037 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.037 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.037 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.037 | |
| atrioventricular node development | GO:0003162 | 3 | 0.037 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.036 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.036 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.036 | |
| cell fate determination involved in pattern specification | GO:0060582 | 1 | 0.036 | |
| inflammatory response | GO:0006954 | 244 | 0.036 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.036 | |
| developmental maturation | GO:0021700 | 193 | 0.036 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.036 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.035 | |
| kidney development | GO:0001822 | 213 | 0.035 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.035 | |
| gliogenesis | GO:0042063 | 141 | 0.035 | |
| bundle of his development | GO:0003166 | 4 | 0.035 | |
| regulation of translation | GO:0006417 | 71 | 0.034 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.034 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.034 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.034 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.034 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.034 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.034 | |
| glial cell development | GO:0021782 | 54 | 0.034 | |
| cell growth | GO:0016049 | 130 | 0.033 | |
| regulation of ion transport | GO:0043269 | 215 | 0.033 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.033 | |
| atrioventricular node cell development | GO:0060928 | 2 | 0.033 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.032 | |
| positive regulation of ion transmembrane transporter activity | GO:0032414 | 15 | 0.032 | |
| protein localization to membrane | GO:0072657 | 108 | 0.032 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.032 | |
| regulation of purine nucleotide biosynthetic process | GO:1900371 | 34 | 0.032 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.032 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.032 | |
| regionalization | GO:0003002 | 337 | 0.031 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.031 | |
| blastocyst development | GO:0001824 | 80 | 0.031 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.031 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.031 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.031 | |
| positive regulation of transmembrane transport | GO:0034764 | 29 | 0.031 | |
| chromatin modification | GO:0016568 | 187 | 0.031 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.031 | |
| cranial nerve development | GO:0021545 | 41 | 0.031 | |
| regulation of cell migration | GO:0030334 | 219 | 0.031 | |
| membrane organization | GO:0061024 | 245 | 0.031 | |
| respiratory tube development | GO:0030323 | 167 | 0.030 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.030 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.030 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.030 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.030 | |
| male sex differentiation | GO:0046661 | 109 | 0.030 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.030 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.029 | |
| chromatin organization | GO:0006325 | 206 | 0.029 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.029 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.029 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.029 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.029 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.028 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.028 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.028 | |
| ventral spinal cord interneuron fate determination | GO:0060580 | 1 | 0.028 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.028 | |
| atrial cardiac muscle cell differentiation | GO:0055011 | 2 | 0.028 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.028 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.028 | |
| positive regulation of sodium ion transport | GO:0010765 | 13 | 0.028 | |
| microtubule based process | GO:0007017 | 236 | 0.027 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.027 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.027 | |
| mesenchyme development | GO:0060485 | 152 | 0.027 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.027 | |
| secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | GO:0060528 | 4 | 0.027 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.027 | |
| ear development | GO:0043583 | 200 | 0.027 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.027 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.027 | |
| hormone metabolic process | GO:0042445 | 86 | 0.026 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.026 | |
| developmental induction | GO:0031128 | 34 | 0.026 | |
| embryonic placenta development | GO:0001892 | 98 | 0.026 | |
| adult behavior | GO:0030534 | 135 | 0.026 | |
| urogenital system development | GO:0001655 | 261 | 0.026 | |
| positive regulation of secondary heart field cardioblast proliferation | GO:0072513 | 4 | 0.026 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.026 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.026 | |
| regulation of white fat cell proliferation | GO:0070350 | 2 | 0.026 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.026 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.026 | |
| connective tissue development | GO:0061448 | 179 | 0.026 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.026 | |
| peptide transport | GO:0015833 | 133 | 0.026 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.026 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.025 | |
| heart morphogenesis | GO:0003007 | 178 | 0.025 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.025 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.025 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.025 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.025 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.025 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.025 | |
| positive regulation of calcium ion transport | GO:0051928 | 27 | 0.025 | |
| positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process | GO:2000763 | 1 | 0.025 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.025 | |
| single organism nuclear import | GO:1902593 | 95 | 0.025 | |
| positive regulation of cyclic nucleotide biosynthetic process | GO:0030804 | 24 | 0.025 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.024 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.024 | |
| glial cell differentiation | GO:0010001 | 131 | 0.024 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.024 | |
| nephron epithelium development | GO:0072009 | 92 | 0.024 | |
| peptide secretion | GO:0002790 | 114 | 0.024 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.024 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.024 | |
| his purkinje system cell differentiation | GO:0060932 | 2 | 0.024 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.024 | |
| intracellular protein transport | GO:0006886 | 204 | 0.024 | |
| atrioventricular node cell fate commitment | GO:0060929 | 1 | 0.024 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.024 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.024 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.023 | |
| neurohypophysis development | GO:0021985 | 2 | 0.023 | |
| positive regulation of calcium ion transmembrane transporter activity | GO:1901021 | 8 | 0.023 | |
| nuclear import | GO:0051170 | 95 | 0.023 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.023 | |
| regulation of camp metabolic process | GO:0030814 | 30 | 0.023 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.023 | |
| regulation of calcium ion transmembrane transport | GO:1903169 | 20 | 0.023 | |
| corticotropin hormone secreting cell differentiation | GO:0060128 | 3 | 0.023 | |
| striated muscle contraction | GO:0006941 | 45 | 0.023 | |
| atrioventricular node cell differentiation | GO:0060922 | 2 | 0.023 | |
| septum transversum development | GO:0003343 | 2 | 0.023 | |
| submandibular salivary gland formation | GO:0060661 | 1 | 0.023 | |
| positive regulation of ion transmembrane transport | GO:0034767 | 24 | 0.023 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.023 | |
| osteoclast differentiation | GO:0030316 | 62 | 0.022 | |
| astrocyte differentiation | GO:0048708 | 43 | 0.022 | |
| positive regulation of high voltage gated calcium channel activity | GO:1901843 | 1 | 0.022 | |
| cardiac right ventricle formation | GO:0003219 | 3 | 0.022 | |
| cell fate commitment | GO:0045165 | 210 | 0.022 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.022 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.022 | |
| anion transport | GO:0006820 | 177 | 0.022 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.022 | |
| digestive system development | GO:0055123 | 200 | 0.022 | |
| carbohydrate transport | GO:0008643 | 62 | 0.022 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.022 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.022 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.022 | |
| fat cell differentiation | GO:0045444 | 160 | 0.022 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.022 | |
| regulation of nucleotide biosynthetic process | GO:0030808 | 34 | 0.022 | |
| mesonephros development | GO:0001823 | 97 | 0.021 | |
| heart contraction | GO:0060047 | 93 | 0.021 | |
| endocrine system development | GO:0035270 | 98 | 0.021 | |
| b cell differentiation | GO:0030183 | 78 | 0.021 | |
| ear morphogenesis | GO:0042471 | 118 | 0.021 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.021 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.021 | |
| heart process | GO:0003015 | 94 | 0.021 | |
| circadian rhythm | GO:0007623 | 114 | 0.021 | |
| sperm egg recognition | GO:0035036 | 37 | 0.021 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.021 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.021 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.021 | |
| neuron migration | GO:0001764 | 122 | 0.021 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.021 | |
| protein import into nucleus | GO:0006606 | 95 | 0.020 | |
| substantia nigra development | GO:0021762 | 2 | 0.020 | |
| his purkinje system development | GO:0003164 | 4 | 0.020 | |
| positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090100 | 43 | 0.020 | |
| tissue remodeling | GO:0048771 | 102 | 0.020 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.020 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.020 | |
| stem cell fate specification | GO:0048866 | 3 | 0.020 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.020 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.020 | |
| regulation of protein transport | GO:0051223 | 163 | 0.020 | |
| glucose homeostasis | GO:0042593 | 128 | 0.020 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.020 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.020 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.020 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.020 | |
| regulation of high voltage gated calcium channel activity | GO:1901841 | 2 | 0.020 | |
| organ or tissue specific immune response | GO:0002251 | 13 | 0.020 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.020 | |
| rna interference | GO:0016246 | 2 | 0.020 | |
| leukocyte migration | GO:0050900 | 124 | 0.020 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.020 | |
| bronchiole development | GO:0060435 | 3 | 0.020 | |
| cardiac pacemaker cell fate commitment | GO:0060927 | 1 | 0.020 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.020 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.020 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.020 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.020 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.019 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.019 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.019 | |
| response to growth factor | GO:0070848 | 198 | 0.019 | |
| positive regulation of fatty acid biosynthetic process | GO:0045723 | 3 | 0.019 | |
| positive regulation of mesenchymal cell proliferation involved in ureter development | GO:2000729 | 3 | 0.019 | |
| regulation of organ growth | GO:0046620 | 61 | 0.019 | |
| protein processing | GO:0016485 | 163 | 0.019 | |
| t cell activation | GO:0042110 | 289 | 0.019 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.019 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.019 | |
| calcium ion transport | GO:0006816 | 159 | 0.019 | |
| lung pattern specification process | GO:0060432 | 1 | 0.019 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.019 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.019 | |
| response to oxidative stress | GO:0006979 | 123 | 0.019 | |
| positive regulation of cation channel activity | GO:2001259 | 8 | 0.019 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.019 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.019 | |
| regulation of calcium ion transmembrane transporter activity | GO:1901019 | 20 | 0.019 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.018 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.018 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.018 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.018 | |
| globus pallidus development | GO:0021759 | 2 | 0.018 | |
| transdifferentiation | GO:0060290 | 1 | 0.018 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.018 | |
| regulation of cyclic nucleotide biosynthetic process | GO:0030802 | 31 | 0.018 | |
| regulation of ossification | GO:0030278 | 112 | 0.018 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.018 | |
| mesenchymal epithelial cell signaling involved in lung development | GO:0060496 | 1 | 0.018 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.018 | |
| regulation of microtubule based process | GO:0032886 | 52 | 0.018 | |
| lung proximal distal axis specification | GO:0061115 | 1 | 0.018 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.018 | |
| regulation of cell motility | GO:2000145 | 236 | 0.018 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.018 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.018 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.018 | |
| steroid metabolic process | GO:0008202 | 119 | 0.018 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.018 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.018 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.018 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.018 | |
| mitral valve development | GO:0003174 | 4 | 0.018 | |
| proepicardium development | GO:0003342 | 2 | 0.018 | |
| pituitary gland development | GO:0021983 | 38 | 0.018 | |
| protein targeting | GO:0006605 | 143 | 0.018 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.018 | |
| placenta development | GO:0001890 | 140 | 0.017 | |
| protein localization to organelle | GO:0033365 | 185 | 0.017 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.017 | |
| regulation of neuron death | GO:1901214 | 134 | 0.017 | |
| adaptive immune response | GO:0002250 | 155 | 0.017 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.017 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.017 | |
| cell recognition | GO:0008037 | 83 | 0.017 | |
| regulation of ph | GO:0006885 | 26 | 0.017 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.017 | |
| stem cell maintenance | GO:0019827 | 130 | 0.017 | |
| metanephric thick ascending limb development | GO:0072233 | 2 | 0.017 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.017 | |
| proton transport | GO:0015992 | 35 | 0.017 | |
| mesoderm formation | GO:0001707 | 62 | 0.017 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.017 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.017 | |
| spinal cord oligodendrocyte cell differentiation | GO:0021529 | 3 | 0.017 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.017 | |
| regulation of tube size | GO:0035150 | 57 | 0.017 | |
| nephron development | GO:0072006 | 109 | 0.017 | |
| embryonic eye morphogenesis | GO:0048048 | 29 | 0.017 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.016 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.016 | |
| digestive tract development | GO:0048565 | 190 | 0.016 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.016 | |
| cytokine secretion | GO:0050663 | 72 | 0.016 | |
| mitochondrion organization | GO:0007005 | 134 | 0.016 | |
| type b pancreatic cell fate commitment | GO:0003327 | 1 | 0.016 | |
| positive regulation of transcription via serum response element binding | GO:0010735 | 1 | 0.016 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.016 | |
| positive regulation of camp metabolic process | GO:0030816 | 19 | 0.016 | |
| gonad development | GO:0008406 | 141 | 0.016 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.016 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.016 | |
| glutamate receptor signaling pathway | GO:0007215 | 35 | 0.016 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.016 | |
| rhombomere 5 development | GO:0021571 | 4 | 0.016 | |
| organelle fission | GO:0048285 | 170 | 0.016 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 26 | 0.016 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.016 | |
| skin morphogenesis | GO:0043589 | 38 | 0.016 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.016 | |
| menarche | GO:0042696 | 1 | 0.016 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.016 | |
| regulation of protein localization | GO:0032880 | 231 | 0.016 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.016 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.016 | |
| neuron death | GO:0070997 | 154 | 0.015 | |
| response to corticosterone | GO:0051412 | 1 | 0.015 | |
| single fertilization | GO:0007338 | 82 | 0.015 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.015 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.015 | |
| cellular response to peptide | GO:1901653 | 92 | 0.015 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.015 | |
| cell fate specification | GO:0001708 | 72 | 0.015 | |
| regulation of thyroid hormone generation | GO:2000609 | 4 | 0.015 | |
| establishment or maintenance of neuroblast polarity | GO:0045196 | 1 | 0.015 | |
| kidney epithelium development | GO:0072073 | 121 | 0.015 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.015 | |
| hexose transport | GO:0008645 | 56 | 0.015 | |
| regulation of cation channel activity | GO:2001257 | 22 | 0.015 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.015 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.015 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.015 | |
| auditory receptor cell differentiation | GO:0042491 | 37 | 0.015 | |
| response to inorganic substance | GO:0010035 | 96 | 0.015 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.015 | |
| dct cell differentiation | GO:0072069 | 3 | 0.015 | |
| negative regulation of mesenchymal cell apoptotic process involved in metanephros development | GO:1900212 | 4 | 0.015 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.015 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.015 | |
| embryonic heart tube formation | GO:0003144 | 1 | 0.015 | |
| atrial cardiac muscle cell development | GO:0055014 | 2 | 0.015 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.015 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.015 | |
| negative regulation of peroxisome proliferator activated receptor signaling pathway | GO:0035359 | 3 | 0.015 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.015 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.015 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.015 | |
| mature b cell differentiation involved in immune response | GO:0002313 | 9 | 0.015 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.014 | |
| cardiac muscle cell proliferation | GO:0060038 | 31 | 0.014 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.014 | |
| binding of sperm to zona pellucida | GO:0007339 | 34 | 0.014 | |
| response to peptide | GO:1901652 | 136 | 0.014 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.014 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.014 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.014 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.014 | |
| pigment metabolic process | GO:0042440 | 32 | 0.014 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.014 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.014 | |
| positive regulation of inositol phosphate biosynthetic process | GO:0060732 | 2 | 0.014 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.014 | |
| renal capsule formation | GO:0072129 | 1 | 0.014 | |
| muscle contraction | GO:0006936 | 101 | 0.014 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.014 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.014 | |
| telencephalon development | GO:0021537 | 186 | 0.014 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.014 | |
| hair follicle development | GO:0001942 | 85 | 0.014 | |
| regulation of oxidative phosphorylation uncoupler activity | GO:2000275 | 3 | 0.014 | |
| positive regulation of stem cell differentiation | GO:2000738 | 23 | 0.014 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.014 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.014 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.014 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.014 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.014 | |
| specification of organ identity | GO:0010092 | 30 | 0.014 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.014 | |
| forebrain regionalization | GO:0021871 | 25 | 0.014 | |
| extracellular structure organization | GO:0043062 | 148 | 0.014 | |
